Meilleur Technologies, Inc. /
Navidea Biopharmaceuticals, Inc.
Meilleur Technologies to purchase Navidea Alzheimer’s business assets
- Terms
- Not stated
- Stage
- Agreement signed




What happened
Meilleur Technologies, Inc. agreed to acquire certain assets and assume certain liabilities of Navidea Biopharmaceuticals, Inc. relating to the development and commercialization of PET biomarkers for Alzheimer’s Disease.
The purchase price is $750, 000, with additional contingent and milestone payments tied to potential licensing events, regulatory milestones and product sales.
The source
Everything on this page comes from the source below.
Meilleur Technologies to purchase Navidea Alzheimer’s business assets
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly